Abstract:Introduction: Tumor heterogeneity is a key element during the development of chemo-resistance and tumor relapse. It remains unknown how resistant tumor cells influence sensitive cells during conditions of cohabitation. The goal of our study was to determine driving factors mediating interactions between resistant and sensitive cancer cells and the effects of cohabitation on both phenotypes. Materials and methods: We used two isogenic ovarian cancer cell lines pairs, sensitive and resistant to platinum: OVCAR5 (IC50 = 2.05 uM) vs. OVCAR5-CisR (IC50 = 7.26 uM) and PEO1 (IC50 = 5.92 uM) vs. PE04 (IC50 = 14.45 uM) labeled with either GFP or RFP. The cell pairs were seeded together in long direct term culture, separated by fluorescence activated cell sorting (FACS), and used for RNAseq analysis, proliferation assays, Cisplatin IC50 determinations, and cell cycle analysis. Results: Long Term direct co-culture (14 Days) of platinum-sensitive and -resistant cells induced increased proliferation (p < 0.001) and a greater proportions of cells in the S and G2 phases of the cell cycle in sensitive PEO1 and OVCAR5 cells compared with cells cultured by themselves. Resistance to platinum of the sensitive cell lines decreased further by co-culture (IC50 change from 5.92 uM to 2.79 uM in PE01, and from 2.05 uM to 1.51 uM in OVCAR5). No changes in cell proliferation, or resistance to platinum occurred in the platinum resistant cells. Use of conditioned media of resistance cells did not change proliferation, or response to platinum of sensitive cells. RNAseq detected 3840 differentially expressed genes; 1774 upregulated and 2066 downregulated. IPA analysis showed enrichment of the cell cycle pathways (Cell Cycle Control, Cyclins and Cell Cycle Regulation, among others) and upregulation of cell proliferation genes including the E2F1 transcription factor. Western blot and qRT-PCR confirmed upregulation of E2F1 in co-cultured platinum sensitive cells vs cells in monoculture. Furthermore, western blot measurements showed increased levels of other proteins involved in cell cycle regulation such as CDK4 and CDK6. Cell cycle analysis indicated an increase of cells in S and G2 phase in the co-cultured platinum sensitive cells (18.8% up G2 phase; p = 0.031). Treatment with the CDK4/6 inhibitor Palbociclib or with the E2F1 inhibitor HLM006474 reverted the increase in proliferation rate. Conclusion: Long term cohabitation of platinum-sensitive and -resistant cancer cells drives sensitive cells to a higher proliferative state, which is more responsive to platinum. Direct cell-cell contact modulates cell cycle progression in sensitive cells through a mechanism regulated by E2F1. Our data reveal unexpected effects caused by interactions between cancer cells with different proliferative rates and levels of platinum resistance, modelling competition between cells in heterogeneous tumors. Citation Format: Andres Felipe Valdivia, Matthew Cowan, Guangyuan Zhao, Horacio Cardenas, Daniela Matei. E2F1 regulates cell competition, increase proliferation and inhibits chemotherapy resistance in cancer cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 2978.

Excessive E2F transcription in single cancer cells precludes transient cell cycle exit after DNA damage

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

Down-regulation of Cyclin E Expression by Caffeine Promotes Cancer Cell Entry into the S-phase of the Cell Cycle.

The broken cycle: E2F dysfunction in cancer

Frequent Mutation of the E2F-4 Cell Cycle Gene in Primary Human Gastrointestinal Tumors.

Expression level is a key determinant of E2F1-mediated cell fate

Overexpression of E2F-1 in Rat Embryo Fibroblasts Leads to Neoplastic Transformation.

Cyclin D1 Affects Epithelial–mesenchymal Transition in Epithelial Ovarian Cancer Stem Cell-Like Cells

Differential Impact of RB Status on E2F1 Reprogramming in Human Cancer

Cyclin E Overexpression in the Drosophila Accessory Gland Induces Tissue Dysplasia.

Abstract 2978: E2F1 regulates cell competition, increase proliferation and inhibits chemotherapy resistance in cancer cells

Upregulation of E2f8 Promotes Cell Proliferation and Tumorigenicity in Breast Cancer by Modulating G1/S Phase Transition

Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest

E2F mediates sustained G2 arrest and down-regulation of Stathmin and AIM-1 expression in response to genotoxic stress

E2F1 is involved in DNA single-strand break repair through cell-cycle-dependent upregulation of XRCC1 expression.

Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts

Canonical and Atypical E2Fs Regulate the Mammalian Endocycle

Negative regulator of E2F transcription factors links cell cycle checkpoint and DNA damage repair

Impaired nuclear export of tumor-derived c-terminal truncated cyclin D1 mutant in ESCC cancer.

The Atypical E2F Family Member E2F7 Couples the P53 and RB Pathways During Cellular Senescence.

Cell cycle control in cancer